Virtual Meeting: Innovative Solutions to Provider Qualification Challenges

Recorded Monday, April 6, 2020

With the rapidly evolving changes in clinical research being driven by the COVID-19 pandemic, now, more than ever, it is essential to engage with your colleagues on proven solutions to challenges.

The objectives of this virtual meeting were to discuss the following:

The impact of COVID-19 on provider qualification.
The evolving clinical trial ecosystem and the pressures to manage a growing provider base.
The unsustainability of current qualification practices in terms of the resource burden, costs, time delays, and inefficiency.
The Tufts-Avoca Benchmarking Data of Industry Qualification Practices.
Openness to the use of standards and a central approach to drive change.
How the Diligent Qualification Platform* addresses the challenges of provider qualification and drives efficiency.

Includes a Q&A session with:

Patty Leuchten

Founder and CEO

The Avoca Group

Brian Whitlock

VP, Head of Global Procurement R&D

Bristol-Myers Squibb

This virtual meeting is ideally suited for industry leaders and executives who oversee provider qualification activities and those in the following roles:

Clinical Operations
Vendor Oversight
Procurement
Quality Management

*The Diligent® Qualification Platform is one approach the industry can take to reduce variability, costs, and cycle times while improving the quality of vendor qualification information to ensure compliance and establish an initial baseline assessment supporting vendor risk management efforts. Diligent’s RFI Database of Vendors includes categories that enable and support adaptive approaches, such as home nursing/monitoring, eCOA, and eConsent.

If you’d like more information about how Diligent can help your organization, contact us.